SS Innovations Reports Record Q1 Revenue, Reduced Losses, and Strong Robotic System Growth
SSII sits 35% above its 52-week low of $3.015.
Summary
SS Innovations reported record Q1 2026 revenue of $11.1 million, a 116.8% increase year-over-year, alongside a reduced net loss and significant growth in SSi Mantra surgical robotic system installations.
Key Events · Earnings and Guidance · SSII
-
Record Quarterly Revenue
Revenue increased 116.8% year-over-year to $11.1 million in Q1 2026, driven by strong growth in SSi Mantra installations and procedures.
-
Improved Profitability
Gross margin expanded to 48.0% from 21.2% in Q1 2025, and net loss reduced to $3.6 million from $5.7 million in the prior year quarter.
-
Strong Operational Expansion
SSi Mantra surgical robotic system installations totaled 26, up 73.3% year-over-year, with the cumulative installed base reaching 194 across eleven countries.
-
Solid Cash Position
The company reported $16.0 million in cash and cash equivalents as of March 31, 2026, with no long-term debt, bolstered by a recent $18.6 million private placement.
Analysis · SSII · Industrial Applications And Services
This filing details strong first-quarter financial and operational results, which are critical for SS Innovations given its recent 'going concern' warnings. The significant revenue growth, improved gross margins, and reduced net loss demonstrate operational progress. The expansion of SSi Mantra installations and regulatory approvals in new markets indicate successful execution of its growth strategy. The improved cash position, following a recent private placement, provides a stronger financial runway as the company pursues entry into the U.S. and European markets.
At the time of this filing, SSII was trading at $4.08 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $823M. The 52-week trading range was $3.02 to $11.87. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.